News & Partnering

Press releases

November 20, 2023

Imvax Presents New Data at 2023 SNO Annual Meeting Supporting its Lead Program, IGV-001, in Newly Diagnosed Glioblastoma

November 10, 2023

Imvax to Present New Data on Lead Program, IGV-001, at 2023 SNO Annual Meeting

September 6, 2023

Imvax Provides Corporate Update

August 8, 2023

Imvax Announces Publication in Journal for ImmunoTherapy of Cancer Showing IGV-001 Can Induce Clinically Relevant Anti-Cancer Immune Responses in Glioblastoma via Immunogenic Cell Death

In the News

September 6, 2023 | Philadelphia Business Journal

Philadelphia biotech company Imvax raises $23M, adds former Spark CFO to board

July 17, 2023 | Cure

Patient Dosed With Novel Combo Immunotherapy in Glioblastoma Trial

Upcoming Events

None at this time, stay tuned!